# 从意向到落地：借助大型语言模型（LLMs）让生物医学研究自动化

发布时间：2024年12月12日

`Agent` `生物医学` `自动化系统`

> From Intention To Implementation: Automating Biomedical Research via LLMs

# 摘要

> 由于科学文献和数据集呈指数级增长，传统的生物医学研究愈发劳动密集。人工智能（AI），尤其是大型语言模型（LLMs），有望通过将各步骤自动化来变革这一流程。不过，仍存在诸多重大挑战，比如需要多学科专业知识、实验设计的逻辑性以及性能衡量。本文介绍了 BioResearcher，这是首个旨在优化涵盖干实验室实验的整个生物医学研究流程的端到端自动化系统。BioResearcher 采用模块化的多智能体架构，整合了用于搜索、文献处理、实验设计和编程的专门智能体。通过把复杂任务分解为逻辑相关的子任务，并运用分层学习方法，BioResearcher 有效应对了多学科需求和逻辑复杂性的难题。此外，BioResearcher 引入了基于 LLM 的审查员进行过程中的质量把控，并推出新的评估指标来评估实验方案的质量和自动化程度。BioResearcher 在八个此前未达成的研究目标中，成功实现了平均 63.07％的执行成功率。生成的方案在五个质量指标上，平均比典型的智能体系统高出 22.0％。该系统展现出巨大潜力，能够减轻研究人员的工作负担，加速生物医学发现，为自动化研究系统的未来创新铺平道路。

> Conventional biomedical research is increasingly labor-intensive due to the exponential growth of scientific literature and datasets. Artificial intelligence (AI), particularly Large Language Models (LLMs), has the potential to revolutionize this process by automating various steps. Still, significant challenges remain, including the need for multidisciplinary expertise, logicality of experimental design, and performance measurements. This paper introduces BioResearcher, the first end-to-end automated system designed to streamline the entire biomedical research process involving dry lab experiments. BioResearcher employs a modular multi-agent architecture, integrating specialized agents for search, literature processing, experimental design, and programming. By decomposing complex tasks into logically related sub-tasks and utilizing a hierarchical learning approach, BioResearcher effectively addresses the challenges of multidisciplinary requirements and logical complexity. Furthermore, BioResearcher incorporates an LLM-based reviewer for in-process quality control and introduces novel evaluation metrics to assess the quality and automation of experimental protocols. BioResearcher successfully achieves an average execution success rate of 63.07% across eight previously unmet research objectives. The generated protocols averagely outperform typical agent systems by 22.0% on five quality metrics. The system demonstrates significant potential to reduce researchers' workloads and accelerate biomedical discoveries, paving the way for future innovations in automated research systems.

[Arxiv](https://arxiv.org/abs/2412.09429)